Stifel Maintains Buy on Precigen, Raises Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Benjamin Burnett maintains a Buy rating on Precigen (NASDAQ:PGEN) and raises the price target from $7 to $10.
June 03, 2024 | 4:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stifel analyst Benjamin Burnett has maintained a Buy rating on Precigen and increased the price target from $7 to $10, indicating strong confidence in the company's future performance.
The increase in the price target from $7 to $10 by a reputable analyst suggests a positive outlook for Precigen's future performance. This is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100